Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 15 | 2020 | 47 | 6.640 |
Why?
|
| Metabolomics | 14 | 2022 | 82 | 5.810 |
Why?
|
| Mass Spectrometry | 18 | 2023 | 188 | 4.770 |
Why?
|
| Metabolome | 7 | 2020 | 66 | 3.020 |
Why?
|
| Machine Learning | 5 | 2022 | 81 | 2.530 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2020 | 113 | 1.810 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2022 | 54 | 1.470 |
Why?
|
| Neoplastic Stem Cells | 2 | 2022 | 138 | 1.280 |
Why?
|
| Proteomics | 3 | 2024 | 177 | 1.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2024 | 151 | 1.120 |
Why?
|
| Cell Communication | 2 | 2024 | 66 | 1.020 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 660 | 0.960 |
Why?
|
| HCT116 Cells | 6 | 2020 | 53 | 0.960 |
Why?
|
| Coculture Techniques | 1 | 2024 | 54 | 0.910 |
Why?
|
| Amlodipine | 1 | 2023 | 8 | 0.890 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 99 | 0.880 |
Why?
|
| Spheroids, Cellular | 3 | 2019 | 53 | 0.820 |
Why?
|
| Nitric Oxide | 1 | 2023 | 152 | 0.820 |
Why?
|
| Trypanosoma cruzi | 1 | 2022 | 20 | 0.790 |
Why?
|
| Chagas Disease | 1 | 2022 | 20 | 0.790 |
Why?
|
| Communicable Diseases | 1 | 2022 | 19 | 0.780 |
Why?
|
| Metformin | 1 | 2022 | 34 | 0.770 |
Why?
|
| Humans | 22 | 2024 | 27165 | 0.740 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 77 | 0.720 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 116 | 0.710 |
Why?
|
| Alkenes | 1 | 2020 | 15 | 0.700 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 71 | 0.700 |
Why?
|
| HeLa Cells | 5 | 2020 | 206 | 0.670 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 12 | 0.670 |
Why?
|
| Phenotype | 2 | 2019 | 668 | 0.670 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 22 | 0.660 |
Why?
|
| Drug Resistance | 1 | 2019 | 42 | 0.650 |
Why?
|
| Signal Transduction | 3 | 2024 | 1379 | 0.640 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 46 | 0.640 |
Why?
|
| Lipids | 1 | 2020 | 199 | 0.640 |
Why?
|
| Nanotechnology | 1 | 2019 | 67 | 0.630 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 16 | 0.630 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 163 | 0.620 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 133 | 0.560 |
Why?
|
| Neoplasms | 2 | 2024 | 768 | 0.550 |
Why?
|
| Brain | 2 | 2019 | 712 | 0.540 |
Why?
|
| Organophosphorus Compounds | 1 | 2016 | 5 | 0.530 |
Why?
|
| Pyrrolidines | 1 | 2016 | 11 | 0.530 |
Why?
|
| K562 Cells | 3 | 2019 | 20 | 0.480 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 1271 | 0.480 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2022 | 6 | 0.360 |
Why?
|
| Discriminant Analysis | 2 | 2019 | 16 | 0.320 |
Why?
|
| Least-Squares Analysis | 2 | 2019 | 17 | 0.320 |
Why?
|
| Limit of Detection | 2 | 2020 | 21 | 0.310 |
Why?
|
| Topoisomerase I Inhibitors | 2 | 2019 | 3 | 0.310 |
Why?
|
| Equipment Design | 2 | 2020 | 212 | 0.300 |
Why?
|
| Animals | 6 | 2022 | 10093 | 0.280 |
Why?
|
| Biomarkers | 2 | 2019 | 738 | 0.250 |
Why?
|
| Paclitaxel | 2 | 2019 | 184 | 0.250 |
Why?
|
| Mice | 4 | 2019 | 4478 | 0.250 |
Why?
|
| Kidney | 2 | 2018 | 276 | 0.250 |
Why?
|
| Mammals | 1 | 2022 | 46 | 0.200 |
Why?
|
| Plant Extracts | 1 | 2022 | 62 | 0.190 |
Why?
|
| Benzophenones | 1 | 2020 | 3 | 0.180 |
Why?
|
| Acetone | 1 | 2020 | 6 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 89 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 280 | 0.170 |
Why?
|
| Integrin beta1 | 1 | 2019 | 15 | 0.170 |
Why?
|
| Integrin alpha3 | 1 | 2019 | 18 | 0.170 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 11 | 0.170 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2019 | 26 | 0.160 |
Why?
|
| Molecular Structure | 1 | 2020 | 240 | 0.160 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 46 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2019 | 775 | 0.160 |
Why?
|
| Deoxycytidine | 1 | 2019 | 63 | 0.160 |
Why?
|
| ROC Curve | 1 | 2019 | 140 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 15 | 0.160 |
Why?
|
| Stochastic Processes | 1 | 2019 | 8 | 0.160 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2019 | 7 | 0.160 |
Why?
|
| Retinal Dehydrogenase | 1 | 2019 | 9 | 0.160 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 60 | 0.160 |
Why?
|
| Sesquiterpenes | 1 | 2019 | 22 | 0.160 |
Why?
|
| Enterovirus | 1 | 2019 | 10 | 0.160 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 50 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 310 | 0.160 |
Why?
|
| Virus Replication | 1 | 2019 | 63 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 122 | 0.150 |
Why?
|
| Receptors, Steroid | 1 | 2019 | 26 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 65 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 102 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2019 | 111 | 0.150 |
Why?
|
| Peptaibols | 1 | 2017 | 7 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 247 | 0.140 |
Why?
|
| Logistic Models | 1 | 2019 | 399 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 31 | 0.140 |
Why?
|
| Ascomycota | 1 | 2017 | 21 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 300 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 288 | 0.140 |
Why?
|
| Phosphatidylglycerols | 1 | 2016 | 3 | 0.130 |
Why?
|
| Phosphatidic Acids | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cations | 1 | 2016 | 11 | 0.130 |
Why?
|
| Phosphatidylserines | 1 | 2016 | 20 | 0.130 |
Why?
|
| Algorithms | 1 | 2018 | 422 | 0.120 |
Why?
|
| Cholestenones | 1 | 2014 | 4 | 0.120 |
Why?
|
| Saponins | 1 | 2014 | 5 | 0.120 |
Why?
|
| Adenosine Diphosphate | 1 | 2014 | 27 | 0.120 |
Why?
|
| Adenosine Monophosphate | 1 | 2014 | 20 | 0.120 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 41 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2014 | 74 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 116 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 516 | 0.110 |
Why?
|
| Receptor, EphA2 | 1 | 2021 | 2 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 11 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 34 | 0.050 |
Why?
|
| Proteome | 1 | 2021 | 76 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 101 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 147 | 0.040 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 15 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 33 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2019 | 53 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 88 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 92 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 131 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 150 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 175 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 313 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 411 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2019 | 62 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 568 | 0.040 |
Why?
|
| Genome, Fungal | 1 | 2017 | 6 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 589 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2017 | 73 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 253 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 445 | 0.030 |
Why?
|
| Male | 1 | 2019 | 13041 | 0.010 |
Why?
|